Inhibikase Therapeutics has appointed Dr. Scott M. Wasserman to its Board of Directors, replacing Dennis Berman. Dr. Wasserman brings over 20 years of clinical development experience, notably from Amgen and Kailera Therapeutics, and will support the advancement of Inhibikase's Phase 3 trial for IKT-001, a novel drug for Pulmonary Arterial Hypertension (PAH). This appointment comes as the company continues enrolling patients in its global IMPROVE-PAH study, aiming to address this serious, life-threatening disease with a promising new treatment.
Inhibikase Therapeutics news comes as 133 of 150 priced Health-sector US stocks tradable on Pluang rose today. For readers following Health stocks, here is Pluang's market snapshot as of Oct 21, 2026 02:12 WIB: Relay Therapeutics Inc. (RLAY) gained 8.95% to USD 18.62 with a typical hold time of 11 days, Teladoc Health Inc (TDOC) rose 8.55% to USD 6.22 despite 99% sell order activity and a typical hold time of 39 days, and Spyre Therapeutics Inc. (SYRE) increased 8.44% to USD 91.87 with a balanced buy-sell order activity and a typical hold time of 2 days.
Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...
Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...
Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Collector Crypt, a Solana-based marketplace that tokenizes physical trading cards, has surpassed both Hyperliquid and Papertrade in 24-hour revenue, reaching over $532,550. This signals a shift in the crypto market towards tokenized collectibles rath...
